Physician profile
Karen Wilder
NPI 1144324500
$15,605.53
in general payments reported to CMS, 2019-2025
11 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $113 · 2023: $11K · 2024: $4,697 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $7,200 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,400 · Travel and Lodging: $3,234 · Food and Beverage: $1,659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $7,200.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,400.00 |
| Travel and Lodging | $3,234.19 |
| Food and Beverage | $1,658.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $10,405.57 | 2022-2023 | Krystexxa |
| Amgen INC. | $4,829.95 | 2024-2025 | Krystexxa |
| Sanofi-Aventis U.S. LLC | $121.60 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $91.62 | 2023-2024 | Livtencity |
| Gilead Sciences, INC. | $28.85 | 2023 | Epclusa |
| Ani Pharmaceuticals, INC. | $27.17 | 2023 | Purified Cortrophin Gel |
| Alexion Pharmaceuticals, INC. | $25.43 | 2025 | Ultomiris |
| Calliditas Therapeutics US INC. | $23.86 | 2024 | |
| Merck Sharp & Dohme LLC | $18.56 | 2024 | Prevymis |
| Mallinckrodt Hospital Products INC. | $17.50 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $15.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Wilder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.